These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 25150608

  • 1. Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).
    Watson R, Wearmouth E, McLoughlin AC, Jackson A, Ward S, Bertram P, Bennaceur K, Barker CE, Pappworth IY, Kavanagh D, Lea SM, Atkinson JP, Goodship TH, Marchbank KJ.
    Mol Immunol; 2015 Feb; 63(2):287-96. PubMed ID: 25150608
    [Abstract] [Full Text] [Related]

  • 2. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E, Alberti M, Iatropoulos P, Piras R, Mele C, Breno M, Cremaschi A, Bresin E, Donadelli R, Alizzi S, Amoroso A, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2019 Feb; 10():853. PubMed ID: 31118930
    [Abstract] [Full Text] [Related]

  • 3. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.
    Foltyn Zadura A, Zipfel PF, Bokarewa MI, Sturfelt G, Jönsen A, Nilsson SC, Hillarp A, Saxne T, Trouw LA, Blom AM.
    Arthritis Res Ther; 2012 Aug 15; 14(4):R185. PubMed ID: 22894814
    [Abstract] [Full Text] [Related]

  • 4. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
    Nuutila J, Jalava-Karvinen P, Hohenthal U, Kotilainen P, Pelliniemi TT, Nikoskelainen J, Lilius EM.
    Hum Immunol; 2013 May 15; 74(5):522-30. PubMed ID: 23376460
    [Abstract] [Full Text] [Related]

  • 5. Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome.
    Guo WY, Song D, Liu XR, Chen Z, Xiao HJ, Ding J, Sun SZ, Liu HY, Wang SX, Yu F, Zhao MH, Chinese Renal-TMA Network.
    Pediatr Nephrol; 2019 Feb 15; 34(2):269-281. PubMed ID: 30315407
    [Abstract] [Full Text] [Related]

  • 6. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C, Togarsimalemath SK, Chauvet S, Le Quintrec M, Moulin B, Buchler M, Jokiranta TS, Roumenina LT, Fremeaux-Bacchi V, Dragon-Durey MA.
    J Immunol; 2015 Jun 01; 194(11):5129-38. PubMed ID: 25917093
    [Abstract] [Full Text] [Related]

  • 7. IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome.
    Cugno M, Berra S, Depetri F, Tedeschi S, Griffini S, Grovetti E, Caccia S, Cresseri D, Messa P, Testa S, Giglio F, Peyvandi F, Ardissino G.
    J Am Soc Nephrol; 2021 May 03; 32(5):1227-1235. PubMed ID: 33712527
    [Abstract] [Full Text] [Related]

  • 8. Indications of underdiagnosis of atypical haemolytic uraemic syndrome in a cohort referred to the Coagulation Unit in Malmo, Sweden, for analysis of ADAMTS13 2007-2012.
    Åkesson A, Blom AM, Klintman J, Zetterberg E.
    Nephrology (Carlton); 2017 Jul 03; 22(7):555-561. PubMed ID: 27175932
    [Abstract] [Full Text] [Related]

  • 9. Complement Factor I Variants in Complement-Mediated Renal Diseases.
    Zhang Y, Goodfellow RX, Ghiringhelli Borsa N, Dunlop HC, Presti SA, Meyer NC, Shao D, Roberts SM, Jones MB, Pitcher GR, Taylor AO, Nester CM, Smith RJH.
    Front Immunol; 2022 Jul 03; 13():866330. PubMed ID: 35619721
    [Abstract] [Full Text] [Related]

  • 10. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
    Mohlin FC, Nilsson SC, Levart TK, Golubovic E, Rusai K, Müller-Sacherer T, Arbeiter K, Pállinger É, Szarvas N, Csuka D, Szilágyi Á, Villoutreix BO, Prohászka Z, Blom AM.
    Mol Immunol; 2015 Jun 03; 65(2):367-76. PubMed ID: 25733390
    [Abstract] [Full Text] [Related]

  • 11. Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission.
    Volokhina EB, Westra D, van der Velden TJ, van de Kar NC, Mollnes TE, van den Heuvel LP.
    Clin Exp Immunol; 2015 Aug 03; 181(2):306-13. PubMed ID: 25079699
    [Abstract] [Full Text] [Related]

  • 12. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
    Kavanagh D, Burgess R, Spitzer D, Richards A, Diaz-Torres ML, Goodship JA, Hourcade DE, Atkinson JP, Goodship TH.
    Mol Immunol; 2007 May 03; 44(12):3162-7. PubMed ID: 17368771
    [Abstract] [Full Text] [Related]

  • 13. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
    D'Cruz OJ, Haas GG.
    Fertil Steril; 1993 Apr 03; 59(4):876-84. PubMed ID: 7681414
    [Abstract] [Full Text] [Related]

  • 14. Characterization of genetic predisposition and autoantibody profile in atypical haemolytic-uraemic syndrome.
    Gurjar BS, Manikanta Sriharsha T, Bhasym A, Prabhu S, Puraswani M, Khandelwal P, Saini H, Saini S, Verma AK, Chatterjee P, Guchhait P, Bal V, George A, Rath S, Sahu A, Sharma A, Hari P, Sinha A, Bagga A.
    Immunology; 2018 Feb 27; 154(4):663-72. PubMed ID: 29485195
    [Abstract] [Full Text] [Related]

  • 15. Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome.
    Strobel S, Hoyer PF, Mache CJ, Sulyok E, Liu WS, Richter H, Oppermann M, Zipfel PF, Józsi M.
    Nephrol Dial Transplant; 2010 Jan 27; 25(1):136-44. PubMed ID: 19666655
    [Abstract] [Full Text] [Related]

  • 16. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
    Thielen AJF, van Baarsen IM, Jongsma ML, Zeerleder S, Spaapen RM, Wouters D.
    J Immunol Methods; 2018 May 27; 456():15-22. PubMed ID: 29447841
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome.
    Nozal P, Bernabéu-Herrero ME, Uzonyi B, Szilágyi Á, Hyvärinen S, Prohászka Z, Jokiranta TS, Sánchez-Corral P, López-Trascasa M, Józsi M.
    Mol Immunol; 2016 Feb 27; 70():47-55. PubMed ID: 26703217
    [Abstract] [Full Text] [Related]

  • 18. Anti-complement-factor H-associated glomerulopathies.
    Durey MA, Sinha A, Togarsimalemath SK, Bagga A.
    Nat Rev Nephrol; 2016 Sep 27; 12(9):563-78. PubMed ID: 27452363
    [Abstract] [Full Text] [Related]

  • 19. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
    Westra D, Volokhina E, van der Heijden E, Vos A, Huigen M, Jansen J, van Kaauwen E, van der Velden T, van de Kar N, van den Heuvel L.
    Nephrol Dial Transplant; 2010 Jul 27; 25(7):2195-202. PubMed ID: 20106822
    [Abstract] [Full Text] [Related]

  • 20. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
    Józsi M, Strobel S, Dahse HM, Liu WS, Hoyer PF, Oppermann M, Skerka C, Zipfel PF.
    Blood; 2007 Sep 01; 110(5):1516-8. PubMed ID: 17495132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.